AU613297B2 - Strontium salt - Google Patents

Strontium salt Download PDF

Info

Publication number
AU613297B2
AU613297B2 AU37092/89A AU3709289A AU613297B2 AU 613297 B2 AU613297 B2 AU 613297B2 AU 37092/89 A AU37092/89 A AU 37092/89A AU 3709289 A AU3709289 A AU 3709289A AU 613297 B2 AU613297 B2 AU 613297B2
Authority
AU
Australia
Prior art keywords
formula
strontium
distrontium salt
salt
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU37092/89A
Other languages
English (en)
Other versions
AU3709289A (en
Inventor
Jacqueline Bonnet
Yannis Tsouderos
Michel Wierzbicki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Servier de Medecine Translationnelle SARL
Original Assignee
ADIR SARL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ADIR SARL filed Critical ADIR SARL
Publication of AU3709289A publication Critical patent/AU3709289A/en
Application granted granted Critical
Publication of AU613297B2 publication Critical patent/AU613297B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyrrole Compounds (AREA)
  • Light Receiving Elements (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
  • Saccharide Compounds (AREA)
AU37092/89A 1988-06-29 1989-06-28 Strontium salt Ceased AU613297B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8808729A FR2633619B1 (fr) 1988-06-29 1988-06-29 Nouveau sel de strontium, son procede de preparation et les compositions pharmaceutiques le renfermant
FR8808729 1988-06-29

Publications (2)

Publication Number Publication Date
AU3709289A AU3709289A (en) 1990-01-04
AU613297B2 true AU613297B2 (en) 1991-07-25

Family

ID=9367847

Family Applications (1)

Application Number Title Priority Date Filing Date
AU37092/89A Ceased AU613297B2 (en) 1988-06-29 1989-06-28 Strontium salt

Country Status (16)

Country Link
US (1) US4939164A (cg-RX-API-DMAC7.html)
EP (1) EP0349432B1 (cg-RX-API-DMAC7.html)
JP (1) JPH0248567A (cg-RX-API-DMAC7.html)
AT (1) ATE81118T1 (cg-RX-API-DMAC7.html)
AU (1) AU613297B2 (cg-RX-API-DMAC7.html)
CA (1) CA1312333C (cg-RX-API-DMAC7.html)
DE (1) DE68903059T2 (cg-RX-API-DMAC7.html)
DK (1) DK325289A (cg-RX-API-DMAC7.html)
ES (1) ES2044170T3 (cg-RX-API-DMAC7.html)
FR (1) FR2633619B1 (cg-RX-API-DMAC7.html)
GR (1) GR3006674T3 (cg-RX-API-DMAC7.html)
IE (1) IE64112B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ229760A (cg-RX-API-DMAC7.html)
OA (1) OA09121A (cg-RX-API-DMAC7.html)
PT (1) PT91006B (cg-RX-API-DMAC7.html)
ZA (1) ZA894945B (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7404967B2 (en) 1994-12-21 2008-07-29 Cosmederm, Inc. Topical product formulations containing strontium for reducing skin irritation
FR2749759B1 (fr) * 1996-06-17 1999-11-26 Adir Utilisation de sels de strontium pour l'obtention de compositions pharmaceutiques destinees au traitement de l'arthrose
PT1534305E (pt) * 2003-05-07 2007-02-28 Osteologix As Tratamento de afecções cartilagineas / osseas com sais de estroncio hidrosoluveis
PT1622630E (pt) * 2003-05-07 2012-10-11 Osteologix As Combinações de estrôncio para a profilaxia/tratamento de patologias da cartilagem e/ou do osso
US20080167513A1 (en) * 2004-02-26 2008-07-10 Osteologlx A/S Strontium-Containing Compounds for Use in the Prevention or Treatment of Necrotic Bone Conditions
DK1768748T4 (da) 2004-06-25 2019-06-11 Mokwalo Spf S A Sammensætninger omfattende strontium og vitamin D og anvendelser deraf
US7875627B2 (en) * 2004-12-07 2011-01-25 Abbott Laboratories Thienopyridyl compounds that inhibit vanilloid receptor subtype 1 (VR1) and uses thereof
EP2530068A1 (en) 2011-05-31 2012-12-05 Lacer, S.A. New strontium salts, synthesis and use thereof in the treatment of osteoporosis
WO2016058753A1 (en) 2014-10-14 2016-04-21 Unilever N.V. Device for spraying an enclosure triggered by inclination of a rotatable lid
US10183308B2 (en) 2014-10-14 2019-01-22 Conopco, Inc. Spraying device

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2954384A (en) * 1960-09-27 Method for preparing kainic acid and its
DE3127275A1 (de) * 1980-12-11 1983-01-27 Leskovar, Peter, Dr.-Ing., 8000 München "harnsteinaufloesende mittel"

Also Published As

Publication number Publication date
IE64112B1 (en) 1995-07-12
ATE81118T1 (de) 1992-10-15
FR2633619B1 (fr) 1991-02-08
CA1312333C (fr) 1993-01-05
JPH0248567A (ja) 1990-02-19
PT91006A (pt) 1989-12-29
GR3006674T3 (cg-RX-API-DMAC7.html) 1993-06-30
IE892094L (en) 1989-12-29
AU3709289A (en) 1990-01-04
PT91006B (pt) 1994-11-30
NZ229760A (en) 1991-06-25
DK325289D0 (da) 1989-06-29
JPH0587064B2 (cg-RX-API-DMAC7.html) 1993-12-15
ES2044170T3 (es) 1994-01-01
DE68903059T2 (de) 1993-04-29
ZA894945B (en) 1990-03-28
EP0349432A1 (fr) 1990-01-03
FR2633619A1 (fr) 1990-01-05
DK325289A (da) 1989-12-30
US4939164A (en) 1990-07-03
OA09121A (fr) 1991-10-31
DE68903059D1 (de) 1992-11-05
EP0349432B1 (fr) 1992-09-30

Similar Documents

Publication Publication Date Title
ES2062450T4 (es) Sales metálicas bivalentes del ácido n,n-di(carboximetil)-2-amino-3-ciano-4-carboximetil-5-carboxi-tiofeno y su procedimiento de preparacion.
DE69524114T2 (de) Naphthyridinonderivate
US4299838A (en) Tryptophan derivatives having an increased effect on the central nervous system
FI82044C (fi) Foerfarande foer framstaellning av ett terapeutiskt aktivt doxepin-, pyridoxin-,2-guanidino-4-(2-metyl-4- imidazolyl)tiazol-, pirbuterol-, isoproterenol- eller trimazosinsalt av piroxicam.
US5190947A (en) Codeine salt of a substituted carboxylic acid, its use and pharmaceutical compositions thereof
US4939164A (en) Strontium salt
SE463366B (sv) Anvaendning av substituerade 4-fenyl-4-oxo-2-butensyraderivat foer framstaellning av laekemedel foer behandling av sjukdomar i matsmaeltningskanalen och som antiulceroest laekemedel
FI63568B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara i 7-staellning substituerade 8-aminometylisoflavonderivat
EP0894794A1 (en) Optical isomers of cloperastine
CN1128999A (zh) 杂环化合物
US4076815A (en) Quinoxaline compound and composition, process for preparing compound, and method of combatting cholera therewith
US3923996A (en) 3-Substituted-oxindoles in compositions and methods of treating obesity
CA1147746A (en) 2-amino-3-(alkylthiobenzoyl)phenylacetic acids
JPS6320426B2 (cg-RX-API-DMAC7.html)
RU2068415C1 (ru) 5,7-диокси-2-метил-8-/4-(3-окси-1-(1-пропил)пиперидинил/-4н-1-бензопиран-4-он или его стереоизомеры или фармакологически приемлемые кислотно-аддитивные соли и способ их получения
JPS63156723A (ja) 骨粗鬆症治療剤
EP0467599A1 (en) N-Alkyl thiazolidine derivatives
US4215143A (en) Anti-ulcer pharmaceutical composition containing inositol hexasulfate aluminum or sodium aluminum salt as active ingredient
SU1072809A3 (ru) Способ получени тиадиазолтетрагидроизохинолина или его фармацевтически приемлемой кислотно-аддитивной соли
US5011974A (en) Process for the preparation of derivative of 2-diethylamino-1-methylethyl-1-hydroxy-(bicyclohexyl)-2-carboxylate
CA1138776A (en) Process for producing d-penicillamine and preparation containing same
KR800000262B1 (ko) 3-아미노-2-하이드록시프로판의 디치환 페놀 에텔 유도체의 제조방법
JPH0629184B2 (ja) 骨粗鬆症治療剤
DE2442910A1 (de) Neue derivate von phenylessigsaeure, verfahren zu ihrer herstellung und pharmazeutische zubereitungen, die die derivate als wirkstoffe enthalten
JPH01501387A (ja) ２―メチルメルカプト―３―シアノ―４―（０―ジフルオロメトキシフェニル）―６―フェニル―１，４―ジヒドロピリジン